Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia)
Creutzfeldt–Jakob disease (CJD) is a rare neurodegenerative disease caused by the accumulation of the pathological isoform of prion protein. The classic clinical presentation of CJD is characterized by rapidly progressive dementia, ataxia, myoclonus, and akinetic mutism at the terminal stage of the...
Published in: | Neurology, Neuropsychiatry, Psychosomatics |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | Russian English |
Published: |
"IMA-Press", LLC
2020
|
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1310 https://doi.org/10.14412/2074-2711-2020-2-86-91 |
_version_ | 1828674278043680768 |
---|---|
author | T. E. Popova A. A. Tappakhov T. K. Davydova T. Ya. Nikolaeva Yu. I. Khabarova M. A. Varlamova L. T. Okoneshinova Т. Е. Попова А. А. Таппахов Т. К. Давыдова Т. Я. Николаева Ю. И. Хабарова М. А. Варламова Л. Т. Оконешникова |
author_facet | T. E. Popova A. A. Tappakhov T. K. Davydova T. Ya. Nikolaeva Yu. I. Khabarova M. A. Varlamova L. T. Okoneshinova Т. Е. Попова А. А. Таппахов Т. К. Давыдова Т. Я. Николаева Ю. И. Хабарова М. А. Варламова Л. Т. Оконешникова |
author_sort | T. E. Popova |
collection | Neurology, Neuropsychiatry, Psychosomatics |
container_issue | 2 |
container_start_page | 86 |
container_title | Neurology, Neuropsychiatry, Psychosomatics |
container_volume | 12 |
description | Creutzfeldt–Jakob disease (CJD) is a rare neurodegenerative disease caused by the accumulation of the pathological isoform of prion protein. The classic clinical presentation of CJD is characterized by rapidly progressive dementia, ataxia, myoclonus, and akinetic mutism at the terminal stage of the disease. Of the instrumental techniques, brain magnetic resonance imaging plays a leading role in clinical practice. The authors followed up 4 patients with probable CJD in the Republic of Sakha (Yakutia) in 2014 to 2019. All the patients had approximately the same age (50–60 years) at disease onset and onset with non-specific cerebral symptoms. However, the subsequent development of rapidly progressive dementia and other characteristic features might suggest CJD. The patients were found to have characteristic neuroimaging signs as hyperintensity of the caudate nuclei and pulvinars in the fluid-attenuated inversion recovery (FLAIR) and diffusion weighted imaging (DWI) modes to form the typical signal of hockey sticks, as well as hyperintensity of the gray matter in the DWI mode (the symptom of the «Venus necklace»). In 3 patients, the disease ended fatally within a year of its onset. The fourth patient with a disease duration of 6 months is being supervised at home. The authors reason that the diagnosis of CJD is now insufficient due to the similarity of its clinical symptoms at the onset with other disorders, including cerebrovascular and neurodegenerative diseases. Болезнь Крейтцфельда–Якоба (БКЯ) является редким нейродегенеративным заболеванием, обусловленным накоплением патологической изоформы прионного белка. Классическая клиническая картина БКЯ характеризуется быстро прогрессирующей деменцией, атаксией, миоклонией, а также акинетическим мутизмом в терминальной стадии заболевания. Из инструментальных методов исследования ведущая роль в клинической практике принадлежит магнитно-резонансной томографии головного мозга. С 2014 по 2019 г. в Республике Саха (Якутия) авторы наблюдали 4 пациентов с вероятной БКЯ. У ... |
format | Article in Journal/Newspaper |
genre | Republic of Sakha Yakutia Саха Якути* Якутия |
genre_facet | Republic of Sakha Yakutia Саха Якути* Якутия |
geographic | Sakha Venus |
geographic_facet | Sakha Venus |
id | ftjnnp:oai:oai.nnp.elpub.ru:article/1310 |
institution | Open Polar |
language | Russian English |
long_lat | ENVELOPE(-57.842,-57.842,-61.925,-61.925) |
op_collection_id | ftjnnp |
op_container_end_page | 91 |
op_relation | https://nnp.ima-press.net/nnp/article/view/1310/1032 https://nnp.ima-press.net/nnp/article/view/1310/1033 Шнайдер НА. Болезнь КрейцфельдаЯкоба: новый взгляд на старую проблему (история изучения, этиология и патогенез). Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;113(4):72-9. Jacobs DA, Lesser RL, Mourelatos Z, et al. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol. 2001;21(2):99-102. doi:10.1097/00041327-200106000-00008. Uttley L, Carroll C, Wong R, et al. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2-e10. doi:10.1016/S1473-3099(19)30615-2. Creutzfeldt-Jakob Disease International Surveillance Network. CJD surveillance data 1993–2018. 2018. http://www.eurocjd.ed.ac.uk/surveillance%20data%201.html Rabinovici GD, Wang PN, Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006 Jan 24;66(2):286-7. doi:10.1212/01.wnl.0000196440.00297.67. Manix M, Kalakoti P, Henri M, et al. Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus. 2015;39(5):E2. doi:10.3171/2015.8.FOCUS15328. Parchi P, De Boni L, Saverioni D, et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol. 2012 Oct;124(4):517-29. doi:10.1007/s00401-012-1002-8. Fragoso DC, Goncalves Filho AL, Pacheco FT, et al. Imaging of Creutzfeldt-Jakob disease: imaging patterns and their differential diagnosis. Radiographics. 2017;37(1):234-257. doi:10.1148/rg.2017160075. Hirst CL. Sporadic Creutzfeldt-Jakob disease presenting as a stroke mimic590. Br J Hosp Med (Lond). 2011;72(10):590-591. doi:10.12968/hmed.2011.72.10.590. Hanumanthu R, Alchaki A, Nyaboga A, et al. An unusual case of sporadic CreutzfeldJacob disease presenting as acute neuropathy. Mov Disord. 2017;32:563-4. Karatas H, Dericioglu N, Kursun O, et al. Creutzfeldt-Jakob disease presenting as hyperparathyroidism and generalized tonic status epilepticus. Clin EEG Neurosci. 2007 Oct; 38(4):203-6. doi:10.1177/155005940703800404. Pachalska M, Kurzbauer H, ForminskaKapuscik M, et al. Atypical features of dementia in a patient with Creutzfeldt-Jakob disease. Med Sci Monit. 2007 Jan;13(1):CS9-19. Epub 2006 Dec 18. Litzroth A, Cras P, De Vil B, Quoilin S. Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998–2012. BMC Neurol. 2015 Dec 2;15:250. doi:10.1186/s12883-015-0507-x. Mahboob HB, Kaokaf KH, Gonda JM. Creutzfeldt-Jakob Disease Presenting as Expressive Aphasia and Nonconvulsive Status Epilepticus. Case Rep Crit Care. 2018:5053175. doi:10.1155/2018/5053175. Ali R, Baborie A, Larner AJ, et al. Psychiatric presentation of sporadic Creutzfeldt-Jakob disease: a challenge to current diagnostic criteria. J Neuropsychiatry Clin Neurosci. 2013;25(4):335-8. doi:10.1176/appi.neuropsych.13020025. Rodriguez-Porcel F, Ciarlariello VB, Dwivedi AK, et al. Movement Disorders in Prionopathies: A Systematic Review. Tremor Other Hyperkinet Mov (NY). 2019;9. doi:10.7916/tohm.v0.712. eCollection 2019. Sakuma T, Watanabe S, Ouchi A, et al. Three Cases of Creutzfeldt-Jakob Disease with Visual Disturbances as Initial Manifestation. Case Rep Ophthalmol. 2019 Oct 23;10(3): 349-356. doi:10.1159/000503274. eCollection 2019 Sep-Dec. Rudge P, Jaunmuktane Z, Adlard P, et al. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain. 2015;138(11): 3386–3399. doi:10.1093/brain/awv235. Thompson A, MacKay A, Rudge P, et al. Behavioral and psychiatric symptoms in prion disease. Am J Psychiatry. 2014;171(3):265-274. doi:10.1176/appi.ajp.2013.12111460. Переседова АВ, Стойда НИ, Гнездицкий ВВ и др. Спорадическая болезнь Крейтцфельдта-Якоба: клиническое наблюдение. Анналы клинической и экспериментальной неврологии. 2011;5(4):52-6. Курушина ОВ, Мирошникова ВВ, Кривоножкина ПС. Случай семейной формы болезни Крейтцфельдта-Якоба. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(9):94-7. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76(20):1711-1719. doi:10.1212/WNL.0b013e31821a4439. Zerr I, Kallenberg K, Summers D, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(10): 2659-2668. doi:10.1093/brain/awp191. Geschwind MD. Prion diseases. Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1612-38. doi:10.1212/CON.0000000000000251. McGuire LI, Peden AH, Orru CD, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic CreutzfeldtJakob disease. Ann Neurol. 2012;72(2):278-285. doi:10.1002/ana.23589. Satoh K, Fuse T, Nonaka T, et al. Postmortem Quantitative Analysis of Prion Seeding Activity in the Digestive System. Molecules. 2019 Dec 16;24(24). pii: E4601. doi:10.3390/molecules24244601. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet. 2001 Jul 21;358(9277):171-80. doi:10.1016/s0140-6736(01)05403-4. Klug GM, Wand H, Boyd A, et al. Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster. Brain. 2009 Feb;132(Pt 2):493-501. doi:10.1093/brain/awn303. Epub 2008 Nov 28. Klug GM, Wand H, Simpson M, et al. Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1372-7. doi:10.1136/jnnp-2012-304820. Epub 2013 Aug 21. |
op_rights | Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся неэксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). |
op_source | Neurology, Neuropsychiatry, Psychosomatics; Vol 12, No 2 (2020); 86-91 Неврология, нейропсихиатрия, психосоматика; Vol 12, No 2 (2020); 86-91 2310-1342 2074-2711 10.14412/2074-2711-2020-2 |
publishDate | 2020 |
publisher | "IMA-Press", LLC |
record_format | openpolar |
spelling | ftjnnp:oai:oai.nnp.elpub.ru:article/1310 2025-04-06T15:04:09+00:00 Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia) Болезнь Крейтцфельда–Якоба в Республике Саха (Якутия) T. E. Popova A. A. Tappakhov T. K. Davydova T. Ya. Nikolaeva Yu. I. Khabarova M. A. Varlamova L. T. Okoneshinova Т. Е. Попова А. А. Таппахов Т. К. Давыдова Т. Я. Николаева Ю. И. Хабарова М. А. Варламова Л. Т. Оконешникова 2020-04-19 application/pdf https://nnp.ima-press.net/nnp/article/view/1310 https://doi.org/10.14412/2074-2711-2020-2-86-91 rus eng rus eng "IMA-Press", LLC https://nnp.ima-press.net/nnp/article/view/1310/1032 https://nnp.ima-press.net/nnp/article/view/1310/1033 Шнайдер НА. Болезнь КрейцфельдаЯкоба: новый взгляд на старую проблему (история изучения, этиология и патогенез). Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;113(4):72-9. Jacobs DA, Lesser RL, Mourelatos Z, et al. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol. 2001;21(2):99-102. doi:10.1097/00041327-200106000-00008. Uttley L, Carroll C, Wong R, et al. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2-e10. doi:10.1016/S1473-3099(19)30615-2. Creutzfeldt-Jakob Disease International Surveillance Network. CJD surveillance data 1993–2018. 2018. http://www.eurocjd.ed.ac.uk/surveillance%20data%201.html Rabinovici GD, Wang PN, Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006 Jan 24;66(2):286-7. doi:10.1212/01.wnl.0000196440.00297.67. Manix M, Kalakoti P, Henri M, et al. Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus. 2015;39(5):E2. doi:10.3171/2015.8.FOCUS15328. Parchi P, De Boni L, Saverioni D, et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol. 2012 Oct;124(4):517-29. doi:10.1007/s00401-012-1002-8. Fragoso DC, Goncalves Filho AL, Pacheco FT, et al. Imaging of Creutzfeldt-Jakob disease: imaging patterns and their differential diagnosis. Radiographics. 2017;37(1):234-257. doi:10.1148/rg.2017160075. Hirst CL. Sporadic Creutzfeldt-Jakob disease presenting as a stroke mimic590. Br J Hosp Med (Lond). 2011;72(10):590-591. doi:10.12968/hmed.2011.72.10.590. Hanumanthu R, Alchaki A, Nyaboga A, et al. An unusual case of sporadic CreutzfeldJacob disease presenting as acute neuropathy. Mov Disord. 2017;32:563-4. Karatas H, Dericioglu N, Kursun O, et al. Creutzfeldt-Jakob disease presenting as hyperparathyroidism and generalized tonic status epilepticus. Clin EEG Neurosci. 2007 Oct; 38(4):203-6. doi:10.1177/155005940703800404. Pachalska M, Kurzbauer H, ForminskaKapuscik M, et al. Atypical features of dementia in a patient with Creutzfeldt-Jakob disease. Med Sci Monit. 2007 Jan;13(1):CS9-19. Epub 2006 Dec 18. Litzroth A, Cras P, De Vil B, Quoilin S. Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998–2012. BMC Neurol. 2015 Dec 2;15:250. doi:10.1186/s12883-015-0507-x. Mahboob HB, Kaokaf KH, Gonda JM. Creutzfeldt-Jakob Disease Presenting as Expressive Aphasia and Nonconvulsive Status Epilepticus. Case Rep Crit Care. 2018:5053175. doi:10.1155/2018/5053175. Ali R, Baborie A, Larner AJ, et al. Psychiatric presentation of sporadic Creutzfeldt-Jakob disease: a challenge to current diagnostic criteria. J Neuropsychiatry Clin Neurosci. 2013;25(4):335-8. doi:10.1176/appi.neuropsych.13020025. Rodriguez-Porcel F, Ciarlariello VB, Dwivedi AK, et al. Movement Disorders in Prionopathies: A Systematic Review. Tremor Other Hyperkinet Mov (NY). 2019;9. doi:10.7916/tohm.v0.712. eCollection 2019. Sakuma T, Watanabe S, Ouchi A, et al. Three Cases of Creutzfeldt-Jakob Disease with Visual Disturbances as Initial Manifestation. Case Rep Ophthalmol. 2019 Oct 23;10(3): 349-356. doi:10.1159/000503274. eCollection 2019 Sep-Dec. Rudge P, Jaunmuktane Z, Adlard P, et al. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain. 2015;138(11): 3386–3399. doi:10.1093/brain/awv235. Thompson A, MacKay A, Rudge P, et al. Behavioral and psychiatric symptoms in prion disease. Am J Psychiatry. 2014;171(3):265-274. doi:10.1176/appi.ajp.2013.12111460. Переседова АВ, Стойда НИ, Гнездицкий ВВ и др. Спорадическая болезнь Крейтцфельдта-Якоба: клиническое наблюдение. Анналы клинической и экспериментальной неврологии. 2011;5(4):52-6. Курушина ОВ, Мирошникова ВВ, Кривоножкина ПС. Случай семейной формы болезни Крейтцфельдта-Якоба. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(9):94-7. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76(20):1711-1719. doi:10.1212/WNL.0b013e31821a4439. Zerr I, Kallenberg K, Summers D, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(10): 2659-2668. doi:10.1093/brain/awp191. Geschwind MD. Prion diseases. Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1612-38. doi:10.1212/CON.0000000000000251. McGuire LI, Peden AH, Orru CD, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic CreutzfeldtJakob disease. Ann Neurol. 2012;72(2):278-285. doi:10.1002/ana.23589. Satoh K, Fuse T, Nonaka T, et al. Postmortem Quantitative Analysis of Prion Seeding Activity in the Digestive System. Molecules. 2019 Dec 16;24(24). pii: E4601. doi:10.3390/molecules24244601. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet. 2001 Jul 21;358(9277):171-80. doi:10.1016/s0140-6736(01)05403-4. Klug GM, Wand H, Boyd A, et al. Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster. Brain. 2009 Feb;132(Pt 2):493-501. doi:10.1093/brain/awn303. Epub 2008 Nov 28. Klug GM, Wand H, Simpson M, et al. Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1372-7. doi:10.1136/jnnp-2012-304820. Epub 2013 Aug 21. Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся неэксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). Neurology, Neuropsychiatry, Psychosomatics; Vol 12, No 2 (2020); 86-91 Неврология, нейропсихиатрия, психосоматика; Vol 12, No 2 (2020); 86-91 2310-1342 2074-2711 10.14412/2074-2711-2020-2 губчатые энцефалопатии Creutzfeldt–Jakob disease dementia myoclonus spongiform encephalopathies болезнь Крейтцфельда–Якоба деменция миоклонии info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 2020 ftjnnp 2025-03-10T08:00:55Z Creutzfeldt–Jakob disease (CJD) is a rare neurodegenerative disease caused by the accumulation of the pathological isoform of prion protein. The classic clinical presentation of CJD is characterized by rapidly progressive dementia, ataxia, myoclonus, and akinetic mutism at the terminal stage of the disease. Of the instrumental techniques, brain magnetic resonance imaging plays a leading role in clinical practice. The authors followed up 4 patients with probable CJD in the Republic of Sakha (Yakutia) in 2014 to 2019. All the patients had approximately the same age (50–60 years) at disease onset and onset with non-specific cerebral symptoms. However, the subsequent development of rapidly progressive dementia and other characteristic features might suggest CJD. The patients were found to have characteristic neuroimaging signs as hyperintensity of the caudate nuclei and pulvinars in the fluid-attenuated inversion recovery (FLAIR) and diffusion weighted imaging (DWI) modes to form the typical signal of hockey sticks, as well as hyperintensity of the gray matter in the DWI mode (the symptom of the «Venus necklace»). In 3 patients, the disease ended fatally within a year of its onset. The fourth patient with a disease duration of 6 months is being supervised at home. The authors reason that the diagnosis of CJD is now insufficient due to the similarity of its clinical symptoms at the onset with other disorders, including cerebrovascular and neurodegenerative diseases. Болезнь Крейтцфельда–Якоба (БКЯ) является редким нейродегенеративным заболеванием, обусловленным накоплением патологической изоформы прионного белка. Классическая клиническая картина БКЯ характеризуется быстро прогрессирующей деменцией, атаксией, миоклонией, а также акинетическим мутизмом в терминальной стадии заболевания. Из инструментальных методов исследования ведущая роль в клинической практике принадлежит магнитно-резонансной томографии головного мозга. С 2014 по 2019 г. в Республике Саха (Якутия) авторы наблюдали 4 пациентов с вероятной БКЯ. У ... Article in Journal/Newspaper Republic of Sakha Yakutia Саха Якути* Якутия Neurology, Neuropsychiatry, Psychosomatics Sakha Venus ENVELOPE(-57.842,-57.842,-61.925,-61.925) Neurology, Neuropsychiatry, Psychosomatics 12 2 86 91 |
spellingShingle | губчатые энцефалопатии Creutzfeldt–Jakob disease dementia myoclonus spongiform encephalopathies болезнь Крейтцфельда–Якоба деменция миоклонии T. E. Popova A. A. Tappakhov T. K. Davydova T. Ya. Nikolaeva Yu. I. Khabarova M. A. Varlamova L. T. Okoneshinova Т. Е. Попова А. А. Таппахов Т. К. Давыдова Т. Я. Николаева Ю. И. Хабарова М. А. Варламова Л. Т. Оконешникова Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia) |
title | Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia) |
title_full | Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia) |
title_fullStr | Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia) |
title_full_unstemmed | Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia) |
title_short | Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia) |
title_sort | creutzfeldt–jakob disease in the republic of sakha (yakutia) |
topic | губчатые энцефалопатии Creutzfeldt–Jakob disease dementia myoclonus spongiform encephalopathies болезнь Крейтцфельда–Якоба деменция миоклонии |
topic_facet | губчатые энцефалопатии Creutzfeldt–Jakob disease dementia myoclonus spongiform encephalopathies болезнь Крейтцфельда–Якоба деменция миоклонии |
url | https://nnp.ima-press.net/nnp/article/view/1310 https://doi.org/10.14412/2074-2711-2020-2-86-91 |